EN
FR
NL

Publications

18Sep2020

Trial Update

PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma—a proof of principle study

14Jul2020

Publication

Repurposing of drugs for triple negative breast cancer: an overview

23Apr2020

Publication

Adoptive T cell therapy beneficial for metastatic melanoma patients that did not respond to standard of care immune therapy.

03Mar2020

Publication

CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infltrating lymphocytes in ovarian cancer

18Feb2020

Publication

Challenges and opportunities for cancer clinical trials in low- and middle-income countries

03Feb2020

Publication

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

03Feb2020

Publication

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

14Jan2020

Publication

Biased by design? Clinical trials and patient benefit in oncology

09Dec2019

POSTER

Low-dose azacytidine, pioglitazone and retinoic acid in ≥ 60 years patients with acute myeloid leukaemia refractory to chemotherapy (AML-ViVA)

05Dec2019

Trial update

Intraoperative ketorolac in High-Risk Breast Cancer Patients. A Prospective, Randomized, Placebo-Controlled Clinical Trial.

05Nov2019

Publication

Journal retractions in oncology: a bibliometric study

26Oct2019

POSTER

Phase I Study of Fluvastatin/Celecoxib Combination in Children with Relapsing or Refractory Low or High Grade Glioma - First Results

30Sep2019

Publication

Lung Cancer Survival Gains: Contributions of Academia and Industry

28Sep2019

POSTER

Pioglitazone and clarithromycin combined with metronomic chemotherapy vs. nivolumab in patients with advanced non-small-cell lung cancer: Outcomes from a randomized phase II trial (ModuLung)

28Aug2019

Publication

Approaches to Advance Cancer Vaccines to Clinical Utility

03Jul2019

Publication

Drug Repurposing

28May2019

Publication

PRIMMO Study Protocol: A Phase II Study Combining PD-1 Blockade, Radiation and Immunomodulation to Tackle Cervical and Uterine Cancer

10Apr2019

Publication

Perioperative therapies - Using repurposed drugs to improve cancer surgery outcomes

05Feb2019

Publication

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

11Jan2019

PUBLICATION

A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer

Pages